|
|
News & Articles
- XinTech China Life Science Industry Newsletter Dec. 2011-January 2012
Feb. 1, 2012
- Syneron Medical Expands Product Portfolio in China
Jan. 24, 2012
- Da An Gene and Life Technologies Form $5.5 Million JV
Jan. 16, 2012
- Amerigen Pharma Announces Two China-US Deals
Jan. 11, 2012
- Vivo Ventures Closes $375 Million US-China Life Science Fund
Jan. 3, 2012
- Hutchison MediPharma Signs $140 Million Cancer Deal with AstraZeneca
Dec. 21, 2011
- Jiangsu Kanion Out-licenses three Molecules to NewGen Therapeutics
Dec. 19, 2011
- Beijing SL Pharmaceutical to Form US-based JV for Curing Diabetes
Dec. 19, 2011
- Simcere and Bristol-Myers Squibb Partner on Cardiovascular Compound
Dec. 13, 2011
- XinTech China Life Science Industry Newsletter October-November 2011
Dec. 1, 2011
- Aslan Pharma In-licenses China Rights to BMS Cancer Drug
Nov. 3, 2011
- Sino-UK Companies Announce TB Vaccine Partnership Deal
Oct. 17, 2011
- WuXi Buys Antibody Maker Abgent
Oct. 14, 2011
- BeiGene In-Licenses Two Potential Cancer Drugs from Janssen
Oct. 14, 2011
- AstraZeneca to Build $200 Million Plant in CMC
Oct. 10, 2011
- Chiva Pharma Acquires Global Rights to Osteoporosis Drug from Ligand
Oct. 10, 2011
- Simcere Partners with Suzhou NeuPharma on Cancer Drug
Oct. 10, 2011
- XinTech China Life Science Industry Newsletter August-September 2011
Oct. 1, 2011
- China’s Push for Low Prices Causes Drug Shortages
Sep. 30, 2011
- Fighting Drug Counterfeiting
Sep. 30, 2011
- 3SBio and Avenue Capital Team Up with CMC for Joint Funds
Sep. 17, 2011
- ShangPharma Forms mAb Partnership with Hengrui Medicine
Sep. 15, 2011
- Fosun Pharma and Lonza to Start Generic Drug Joint Venture
Sep. 7, 2011
- Simcere Clears New Drug by SFDA
Aug. 25, 2011
- WuXi Receives GLP Certificate from OECD and EU
Aug. 23, 2011
- Beijing SL Pharma Forms JV with Canadian Startup
Aug. 16, 2011
- Zhejiang Hisun Group Co Ltd acquires a Minority Stake in PharmTak Inc
Aug. 2, 2011
- XinTech China Life Science Industry Newsletter June-July 2011
Jul. 31, 2011
- 3SBio got SFDA Approval for EPIAO
Jul. 11, 2011
- MingSight and Relin Medicine Form China Ophthalmology JV
Jul. 5, 2011
- MedicaNova and Zhejiang Medicine Announce Asthma-focused JV
Jun. 30, 2011
- Sinovac to Begin Phase II Trial of Proprietary Vaccine
Jun. 28, 2011
- Sirnaomics Partnering with Zhongsheng Pharma for siRNA Therapeutic Development
Jun. 23, 2011
- Conba Pharma Forms JV with American Kite Pharma to Develop Cancer Treatment
Jun. 14, 2011
- XinTech China Life Science Industry Newsletter April-May 2011
Jun. 1, 2011
- Biotech a Priority in China’s $309 Billion Five-Year Plan
Jun. 1, 2011
- VCs Show Increasing Interest in Healthcare Companies
Jun. 1, 2011
- Another XinTech Success Story: D-Pharm Signs Chinese Deal for Epilepsy Drug
May. 31, 2011
- Sinovac Announces Success for Phase I Trial of EV71 Vaccine
May. 25, 2011
- Chongqing Zhifei Bidding to Buy Dutch Vaccine Company
May. 13, 2011
- First Chinese Company to Launch Drug in the US
May. 4, 2011
- BeiGene Lands Large Investment from Merck
May. 2, 2011
- China Ramps-up its Regulatory Capabilities for Evaluation of New Drugs
May. 1, 2011
- Kinex Licenses China Rights for Cancer Molecule to Hanmi Pharma
Apr. 21, 2011
- SciClone to Acquire NovaMed Pharma for ~$62 Million
Apr. 19, 2011
- New U.S.-China Drug Development Company Announces Huge Investment
Apr. 6, 2011
- XinTech China Life Science Industry Newsletter January-March 2011
Apr. 1, 2011
- Dainippon Sumitomo Enters into a Licensing Agreement for a Treatment for Chronic Liver Disease
Mar. 30, 2011
- Kang Sheng Bao to Develop Immune System Diagnostic Test for SuperNova
Mar. 30, 2011
- Zhejiang Hisun Pharma Invests in US Biotech Startup
Mar. 25, 2011
- XinTech China Life Science Industry Newsletter Nov.-Dec. 2010
Dec. 30, 2010
- Fosun Acquires Anti-Tuberculosis Company
Dec. 14, 2010
- GSK to Acquire Nanjing MeiRui Pharmaceuticals
Dec. 7, 2010
- Capping Pharmaceutical Drugs’ Prices
Dec. 1, 2010
- Attending to the Health Service Gap in Rural China
Dec. 1, 2010
- Shanghai Pharma to Acquire China Health System Ltd.
Nov. 30, 2010
- 3SBio in-licensed Pegsiticase Global Rights
Nov. 29, 2010
- Sihuan Pharma Acquired Dupromise
Nov. 25, 2010
- Yunnan Walvax Completes IPO
Nov. 12, 2010
- Simcere and BMS Collaboration on Co-development of Early-Stage Oncology Drug
Nov. 3, 2010
- XinTech China Life Science Industry Newsletter Sep.-Oct. 2010
Nov. 1, 2010
- Canon Healthcare is Seeking New Opportunities in Rural China
Oct. 30, 2010
- ShangPharma Listed on NYSE
Oct. 19, 2010
- Livzon Pharma to Invest $300 Million in New Bio Facilities
Oct. 18, 2010
- Burrill and Infinity Set Up JV to Invest in China Healthcare
Oct. 12, 2010
- Pfizer Opens R&D Center in Wuhan
Oct. 10, 2010
- Tasly Pharma and ProteoTech Join Hands on Alzheimer’s Drug
Oct. 5, 2010
- MOH May Allow Wholly Foreign Owned Hospitals to Operate in China
Oct. 1, 2010
- WuXi PharmaTech Awarded GLP for Suzhou Facility
Sep. 20, 2010
- SIMM to Collaborate with Oslo Cancer Center
Sep. 16, 2010
- Bayer Builds China Diabetes Portfolio with SciLin Launch
Sep. 3, 2010
- XinTech China Life Science Industry Newsletter July-August 2010
Sep. 1, 2010
- Simcere Pharmaceutical Group Announces SFDA Approval to Manufacture and Market Palonosetron in China
Aug. 12, 2010
- Sinobiopharma and Lianhuan Sign Agreement for Eplerenone
Aug. 11, 2010
- China’s first TCM drug approved by the FDA for Phase III trials
Aug. 7, 2010
- Chinese Pharmaceutical Revenues Last Year exceeded $140 Billion
Aug. 1, 2010
- Charles River Terminates Acquisition Plans of WuXi Pharma Tech
Jul. 29, 2010
- Merck and Sinopharm Collaboration in China
Jul. 27, 2010
- China Nuokang Bio-Pharmaceutical Announces Agreement to Market Dianatal Obstetric Gel in China
Jul. 1, 2010
- XinTech China Life Science Industry Newsletter May-June 2010
Jun. 30, 2010
- China Likely to Nullify Rx/OTC Dual Status of Drugs
Jun. 10, 2010
- Mindray and Pulsion sign Licensing Agreement
Jun. 10, 2010
- Chinese Stomach Vaccine May Stop Gastric Cancer
Jun. 2, 2010
- Dehaier Medical Expands Product Line with a Series of Exclusive Distribution Agreements
Jun. 1, 2010
- Pfizer's China Swine Vaccine Unit Sold To Harbin Pharmaceutical Group
May. 29, 2010
- Qiming Venture Partners to Invest RMB 100 Million in GanLee Pharmaceuticals
May. 19, 2010
- Beijing Genomics Institute Sets its Headquarter in Copenhagen
May. 17, 2010
- Hepalink Sets the Highest Issue Price in A-Share Market
May. 6, 2010
- XinTech China Life Science Industry Newsletter March-April 2010
May. 1, 2010
- Tasly: Influenza Subunit Vaccine Gets SFDA Approval
Apr. 30, 2010
- Charles River Acquires Wuxi Pharma for $1.6 billion
Apr. 26, 2010
- Sanofi-Aventis Opens R&D Center in China
Apr. 13, 2010
- Aoxing Pharmaceutical Company Approved to List on NYSE AMEX
Apr. 13, 2010
- Cord Blood America Licenses Technology to Chinese AXM Pharma
Mar. 31, 2010
- Management Center Established for Medical Device Standards
Mar. 30, 2010
- Eli Lilly to Launch 15 New Products in China within 5 Years
Mar. 30, 2010
- Merck Serono China Branch to Settle in Beijing Tianzhu Free Trade Zone
Mar. 22, 2010
- XinTech China Life Science Industry Newsletter Jan.-Feb. 2010
Mar. 1, 2010
- China Aoxing and QRxPharma Announce a Development Alliance
Feb. 23, 2010
- 3SBio Closes Two Equity Investment and Licensing Transactions in 4 Days
Feb. 11, 2010
- New Drug GMP to Emphasize the Human Factor
Feb. 1, 2010
- XinTech China Life Science Industry Newsletter Nov.-Dec. 2009
Dec. 31, 2009
- Pfizer Extends Relationship with Beijing University
Dec. 20, 2009
- Lilly Hopes China Business Continues to Flourish with New Corporate Initiatives
Dec. 10, 2009
- MOH, Roche Set Sights on HCV Prevention and Treatment
Dec. 1, 2009
- PPD Continues China Acquisitions, Takes Over BioDuro
Nov. 30, 2009
- Pfizer to Build New Clinical R&D Center in Wuhan
Nov. 25, 2009
- MOH, NDRC, MOHRSS Release Drug, Medical Service Pricing Omnibus
Nov. 23, 2009
- Novartis Opens Plant and Technical R&D Center
Nov. 3, 2009
- XinTech China Life Science Industry Newsletter Sep.-Oct. 2009
Oct. 31, 2009
|
|
